Skip to main navigation Skip to search Skip to main content

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment

  • Javier P. Gisbert*
  • , Maria Chaparro
  • , Bram Verstockt
  • , Peter Kienle
  • , Silvia Minozzi
  • , Mariangela Allocca
  • , Raja Atreya
  • , Nicolas Avellaneda
  • , Manuel Barreiro-de Acosta
  • , Robert Battat
  • , Dominik Bettenworth
  • , Irina Blumenstein
  • , Steven R. Brown
  • , John P. Burke
  • , Flavio Caprioli
  • , Maria Jose Casanova
  • , Niki Christou
  • , Anthony de Buck van Overstraeten
  • , Glen Doherty
  • , Piotr Eder
  • Alaa El-Hussuna, Pierre Ellul, Massimo Claudio Fantini, Federica Furfaro, Thomas Greuter, Karl Hazel, Stefan Holubar, Christina Kapizioni, Uri Kopylov, Rupert W. Leong, Sezai Leventoglu, Jimmy K. Limdi, Nurulamin M. Noor, Ioannis Papaconstantinou, Georgios Peros, Lieven Pouillon, Catherine Reenaers, Simone Saibeni, Carsten Schmidt, Paula Sousa, Laurents P. S. Stassen, Mathieu Uzzan, Sophie Vieujean, Eva Visser, Par Myrelid, Michel Adamina, Torsten Kucharzik
*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original languageEnglish
Article numberjjag066
Number of pages39
JournalJournal of Crohn's & Colitis
Volume20
Issue number7
DOIs
Publication statusPublished - 1 Jul 2026

Keywords

  • ulcerative colitis
  • guideline
  • medical treatment
  • advanced therapies
  • biologics
  • small molecules
  • INFLAMMATORY-BOWEL-DISEASE
  • RANDOMIZED CONTROLLED-TRIAL
  • FECAL MICROBIOTA TRANSPLANTATION
  • RELEASE ORAL MESALAMINE
  • 5-AMINOSALICYLIC ACID ENEMAS
  • QUALITY-OF-LIFE
  • DOUBLE-BLIND
  • MAINTENANCE THERAPY
  • BECLOMETHASONE DIPROPIONATE
  • TOPICAL TREATMENT

Cite this